Charles Schwab Investment Management Inc. Sells 6,140 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Charles Schwab Investment Management Inc. decreased its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 4.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 148,901 shares of the company’s stock after selling 6,140 shares during the period. Charles Schwab Investment Management Inc. owned about 0.99% of U.S. Physical Therapy worth $12,601,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of USPH. Renaissance Technologies LLC grew its holdings in U.S. Physical Therapy by 763.7% during the 2nd quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock worth $6,425,000 after acquiring an additional 61,474 shares during the last quarter. Penn Davis Mcfarland Inc. bought a new stake in shares of U.S. Physical Therapy in the 3rd quarter valued at $2,552,000. Dimensional Fund Advisors LP increased its holdings in shares of U.S. Physical Therapy by 2.5% in the second quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock worth $39,173,000 after acquiring an additional 10,462 shares in the last quarter. Envestnet Asset Management Inc. increased its stake in U.S. Physical Therapy by 4.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 239,982 shares of the company’s stock worth $22,179,000 after purchasing an additional 9,434 shares in the last quarter. Finally, Semanteon Capital Management LP acquired a new stake in shares of U.S. Physical Therapy during the third quarter worth $776,000.

U.S. Physical Therapy Stock Performance

NYSE:USPH opened at $96.08 on Monday. The firm has a market capitalization of $1.45 billion, a P/E ratio of 102.21, a P/E/G ratio of 4.34 and a beta of 1.46. The company has a fifty day moving average of $88.04 and a 200-day moving average of $90.09. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were issued a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 1.83%. The ex-dividend date of this dividend was Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio is presently 187.23%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on USPH shares. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Barrington Research reiterated an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. Bank of America reiterated a “neutral” rating and set a $90.00 price objective (down previously from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. Finally, JPMorgan Chase & Co. raised their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd.

Insider Activity

In other U.S. Physical Therapy news, Director Nancy Ham sold 1,172 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the sale, the director now directly owns 1,112 shares in the company, valued at $107,552.64. The trade was a 51.31 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total value of $185,900.00. Following the transaction, the director now directly owns 16,726 shares in the company, valued at approximately $1,554,681.70. This represents a 10.68 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,896 shares of company stock valued at $656,940 in the last ninety days. 1.70% of the stock is currently owned by insiders.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.